are the glp 1 drugs safe GLP-1 Medications Infographic FDA warns about unapproved GLP-1

Glossary CKD c hronic kidney disease CNS central nervous system CVD c ardiovascular disease FDA Food and Drug Administration GLP-1 glucagon-like peptide-1 GLP-1s glucagon-like peptide-1 receptor agonists HF Heart failure MASH metabolic dysfunction-associated steatohepatitis OA osteoarthritis OSA obstructive sleep apnea PAD peripheral arterial disease SC subcutaneous T2DM type 2 diabetes mellitus U.S

However, Ex had a slightly stronger effect on the consumption of the more palatable food (mean SE average Treatment effect: 15.4 6.5 g against Vehicle and 16.2 9.5 g against Baseline) compared to the effect for the less palatable food ( 2.8 5.9 g against Vehicle and 3.2 6.7 g against Baseline) as supported by a Treatment S2 meal type interaction (using Vehicle days as control: F 1,4 = 12.37, p = 0.025

50 Lixisenatide Drugs and Lactation Database (2023)

It does not activate GLP-1 receptors directly

Hsu TM, Noble EE, Liu CM, Cortella AM, Konanur VR, Suarez AN, et al

These drugs, while effective for weight loss or controlling diabetes, can trigger rapid changesweight loss, hormonal fluctuations, and this perceived stress on the body can lead to excessive shedding or hair thinning